Trial · NCT03440372
Results by group72
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 72
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent of Participants With a Crohn's Disease Activity Index (CDAI) Score < 150 at Week 12 | Treatment 1 | Responders | 31.3 | Percentage of Participants | |
| Percent of Participants With a Crohn's Disease Activity Index (CDAI) Score < 150 at Week 12 | Treatment 2 | Responders | 20.8 | Percentage of Participants | |
| Percent of Participants With a Crohn's Disease Activity Index (CDAI) Score < 150 at Week 12 | Treatment 1 | Non-Responders | 64.4 | Percentage of Participants | |
| Percent of Participants With a Crohn's Disease Activity Index (CDAI) Score < 150 at Week 12 | Treatment 2 | Non-Responders | 73.4 | Percentage of Participants | |
| Percent of Participants With a Crohn's Disease Activity Index (CDAI) Score < 150 at Week 12 | Treatment 1 | Imputed Non-Responders | 4.3 | Percentage of Participants | |
| Percent of Participants With a Crohn's Disease Activity Index (CDAI) Score < 150 at Week 12 | Treatment 2 | Imputed Non-Responders | 5.8 | Percentage of Participants | |
| Percent of Participants With Average Daily Abdominal Pain Score ≤ 1 Point, and Average Daily Stool Frequency Score ≤ 3 Points With Abdominal Pain and Stool Frequency no Worse Than Baseline at Week 12 | Treatment 1 | Responders | 30.5 | Percentage of Participants | |
| Percent of Participants With Average Daily Abdominal Pain Score ≤ 1 Point, and Average Daily Stool Frequency Score ≤ 3 Points With Abdominal Pain and Stool Frequency no Worse Than Baseline at Week 12 | Treatment 2 | Responders | 21.7 | Percentage of Participants | |
| Percent of Participants With Average Daily Abdominal Pain Score ≤ 1 Point, and Average Daily Stool Frequency Score ≤ 3 Points With Abdominal Pain and Stool Frequency no Worse Than Baseline at Week 12 | Treatment 1 | Non-Responders | 66.3 | Percentage of Participants | |
| Percent of Participants With Average Daily Abdominal Pain Score ≤ 1 Point, and Average Daily Stool Frequency Score ≤ 3 Points With Abdominal Pain and Stool Frequency no Worse Than Baseline at Week 12 | Treatment 2 | Non-Responders | 72.5 | Percentage of Participants | |
| Percent of Participants With Average Daily Abdominal Pain Score ≤ 1 Point, and Average Daily Stool Frequency Score ≤ 3 Points With Abdominal Pain and Stool Frequency no Worse Than Baseline at Week 12 | Treatment 1 | Imputed Non-Responders | 3.1 | Percentage of Participants | |
| Percent of Participants With Average Daily Abdominal Pain Score ≤ 1 Point, and Average Daily Stool Frequency Score ≤ 3 Points With Abdominal Pain and Stool Frequency no Worse Than Baseline at Week 12 | Treatment 2 | Imputed Non-Responders | 5.8 | Percentage of Participants | |
| Percent of Participants With a Simple Endoscopic Score for Crohn's Disease (SES-CD) Score Decrease From Baseline of ≥ 50% at Week 12 | Treatment 1 | Responders | 22.1 | Percentage of Participants | |
| Percent of Participants With a Simple Endoscopic Score for Crohn's Disease (SES-CD) Score Decrease From Baseline of ≥ 50% at Week 12 | Treatment 2 | Responders | 18.4 | Percentage of Participants | |
| Percent of Participants With a Simple Endoscopic Score for Crohn's Disease (SES-CD) Score Decrease From Baseline of ≥ 50% at Week 12 | Treatment 1 | Non-Responders | 71.6 | Percentage of Participants | |
| Percent of Participants With a Simple Endoscopic Score for Crohn's Disease (SES-CD) Score Decrease From Baseline of ≥ 50% at Week 12 | Treatment 2 | Non-Responders | 77.3 | Percentage of Participants | |
| Percent of Participants With a Simple Endoscopic Score for Crohn's Disease (SES-CD) Score Decrease From Baseline of ≥ 50% at Week 12 | Treatment 1 | Imputed Non-Responders | 6.3 | Percentage of Participants | |
| Percent of Participants With a Simple Endoscopic Score for Crohn's Disease (SES-CD) Score Decrease From Baseline of ≥ 50% at Week 12 | Treatment 2 | Imputed Non-Responders | 4.3 | Percentage of Participants | |
| Percent of Participants With Crohn's Disease Activity Index (CDAI) Reduction From Baseline of ≥ 100 Points or CDAI Score < 150 at Week 12 | Treatment 1 | Responders | 48.8 | Percentage of Participants | |
| Percent of Participants With Crohn's Disease Activity Index (CDAI) Reduction From Baseline of ≥ 100 Points or CDAI Score < 150 at Week 12 | Treatment 2 | Responders | 39.1 | Percentage of Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03440372/results